Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2012	Sep. 25, 2011
Cash flows from operating activities
Net earnings	$ 205,700	$ 246,237
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation of plant and equipment	75,113	85,039
Amortization of intangibles	34,792	32,378
Program production cost amortization	25,950	18,082
Deferred income taxes	(1,694)	(23,344)
Stock-based compensation	18,040	24,190
Change in operating assets and liabilities:
Increase in accounts receivable	(141,259)	(316,896)
Increase in inventories	(125,472)	(167,726)
Increase in prepaid expenses and other current assets	(196)	(63,408)
Program production costs	(41,195)	(60,603)
Increase in accounts payable and accrued liabilities	72,486	228,805
Other, including long-term advances	21,351	(1,708)
Net cash provided by operating activities	143,616	1,046
Cash flows from investing activities
Additions to property, plant and equipment	(74,896)	(71,675)
Investments and acquisitions, net of cash acquired	0	(11,585)
Other investing activities	2,558	4,902
Net cash utilized by investing activities	(72,338)	(78,358)
Cash flows from financing activities
Net proceeds (repayments) from short-term borrowings	83,380	(13)
Purchases of common stock	(15,079)	(384,800)
Stock option transactions	40,661	25,721
Excess tax benefits from stock-based compensation	8,521	8,969
Dividends paid	(132,231)	(115,330)
Net cash utilized by financing activities	(14,748)	(465,453)
Effect of exchange rate changes on cash	(1,485)	1,931
Increase (decrease) in cash and cash equivalents	55,045	(540,834)
Cash and cash equivalents at beginning of year	641,688	727,796
Cash and cash equivalents at end of period	696,733	186,962
Cash paid during the period for:
Interest	79,724	77,023
Income taxes	$ 50,446	$ 26,897